Maclent Pharma Private Limited
About Maclent Pharma Private Limited
Data last updated:
Maclent Pharma Private Limited is a private limited company based in New, Delhi, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 10 November 2022.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24110DL2022PTC406652.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹20,000. It is led by directors Ravi Kumar and Soni Kumari.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H.No.43A Gali No.14 Sainik Enclave Press Enc Part – III, Vikas Nagar Uttam Nagar, New, Delhi, India – 110059.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressH.No.43A Gali No.14 Sainik Enclave Press Enc Part – III, Vikas Nagar Uttam Nagar, New, Delhi, India – 110059
- IndustryChemicals, Manufacturing, Basic Chemical, Basic Chemicals Except Fertilizers And Nitrogen Compounds
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Board of Directors of Maclent Pharma Private Limited
Maclent Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ravi Kumar | Director | 10 Nov 2022 | 3 Years 10 Months | Current |
| Soni Kumari | Director | 10 Nov 2022 | 3 Years 10 Months | Current |
Financials of Maclent Pharma Private Limited FY 2025 filings available
Financial Statement Summary of Maclent Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• |
| EBITDA | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• |
| Net Profit (PAT) | •••• | •••• | •••• |
| Balance Sheet | |||
| Share Capital | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• |
Financial Ratios of Maclent Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | •••• | •••• | •••• |
| Net Profit Margin | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• |
| Liquidity and Debt | |||
| Current Ratio | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• |
| Efficiency and Growth | |||
| Asset Turnover | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Maclent Pharma are in the company report.
Financial statements from FY 2023
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Charges & Borrowings of Maclent Pharma Private Limited
Maclent Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Maclent Pharma Private Limited
Employment history and EPFO contributions of people linked to Maclent Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Maclent Pharma Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Maclent Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Maclent Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Maclent Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Maclent Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Maclent Pharma Private Limited
Frequently Asked Questions about Maclent Pharma Private Limited
Maclent Pharma is an active private limited company based in New, Delhi, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 10 November 2022 (4+ years old) and is registered under CIN U24110DL2022PTC406652.
Maclent Pharma has 2 current directors:
- Ravi Kumar - Director
- Soni Kumari - Director
The CIN (Corporate Identification Number) of Maclent Pharma is U24110DL2022PTC406652. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Maclent Pharma was incorporated on 10 November 2022, making it 4+ years old. It is registered with the Registrar of Companies, Delhi.
The registered office of Maclent Pharma is at H.No.43A Gali No.14 Sainik Enclave Press Enc Part – III, Vikas Nagar Uttam Nagar, New, Delhi, India – 110059.
Maclent Pharma has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹20,000.
Maclent Pharma operates in the chemicals industry, in the manufacturing segment.
No. Maclent Pharma is not listed on any stock exchange. It is an unlisted company.
The compliance status of Maclent Pharma is compliant as of 27 July 2026. The company is actively filing with the Registrar of Companies.